Optimized Protocol for the Incorporation of FDAA (HADA Labeling) for in situ Labeling of Peptidoglycan. (2019)

First Author: Peters K
Attributed to:  NAPCLI: Non-conventional approaches for peptidoglycan cross-linking inhibition funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21769/bioprotoc.3316

PubMed Identifier: 33654824

Publication URI: http://europepmc.org/abstract/MED/33654824

Type: Journal Article/Review

Volume: 9

Parent Publication: Bio-protocol

Issue: 15

ISSN: 2331-8325